APA (7th ed.) Citation

Duchek, M., Wiklund, F., Jahnson, S., Mestad, O., Hellström, P., Hellsten, S., & Malmström, P. (2007). POD-09.03: Endovesical epirubicin and interferon α 2b is comparable to BCG as adjuvant treatment for T1 tumours with or without CIS. Urology, 70(3), 28. https://doi.org/10.1016/j.urology.2007.06.109

Chicago Style (17th ed.) Citation

Duchek, M., F. Wiklund, S. Jahnson, O. Mestad, P. Hellström, S. Hellsten, and P.U Malmström. "POD-09.03: Endovesical Epirubicin and Interferon α 2b Is Comparable to BCG as Adjuvant Treatment for T1 Tumours with or Without CIS." Urology 70, no. 3 (2007): 28. https://doi.org/10.1016/j.urology.2007.06.109.

MLA (9th ed.) Citation

Duchek, M., et al. "POD-09.03: Endovesical Epirubicin and Interferon α 2b Is Comparable to BCG as Adjuvant Treatment for T1 Tumours with or Without CIS." Urology, vol. 70, no. 3, 2007, p. 28, https://doi.org/10.1016/j.urology.2007.06.109.